sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
U.S. Skin Graft Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

U.S. Skin Graft Market Analysis, Companies Profiles, Size, Share, Growth,...

Home / Categories / Healthcare
U.S. Skin Graft Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
U.S. Skin Graft Market Analysis,...
Report Code
RO1/110/1330

Publish Date
01/Feb/2018

Pages
84
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
U.S. skin graft market is expected to reach USD 522.52 million by 2025 from USD 293.00 million in 2017, at a CAGR of 7.6% in the forecast period 2018 to 2025.
The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and skin infections, developments in skin grafting techniques and technological advances in dermatomes are boosting the growth of the U.S. skin graft market.
The key market players for U.S. skin graft market are listed below;

Integra Lifesciences Corporation
Organogenesis, Inc.
Zimmer Biomet, Inc.
B. Braun Melsungen AG
Nouvag AG
DE Soutter Medical Limited
Surtex Instruments Limited
Exsurco Medical, Inc.

The market is further segmented into;
Type
Graft Thickness
Application
Equipment Type
End-user

The U.S. skin graft market is segmented on the basis of type, graft thickness, application, equipment type, and end-user. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The U.S. skin graft market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. skin graft market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.
The U.S. skin graft market is segmented based on graft thickness into split-thickness, full-thickness, and composite graft. In 2018, split-thickness is expected to dominate the U.S. skin graft market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on application into burns, extensive wound, skin cancer, and extensive skin loss due to infection. In 2018, burns is expected to dominate the U.S. skin graft market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the U.S. Skin graft market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin graft market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.
Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the U.S. skin graft market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. skin grafts market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. skin graft market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the U.S. skin graft market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.




OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com